B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome-Reference-Cited by-同舟云学术

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome

Published:2011-10-14 Issue:1 Volume:25 Page:145-156
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Li Shaoying,Lin Pei,Fayad Luis E,Lennon Patrick A,Miranda Roberto N,Yin C Cameron,Lin E,Medeiros L Jeffrey

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2011147.pdf

Reference30 articles.

1. Lenz G, Staudt LM . Aggressive lymphomas. N Engl J Med 2010;362:1417–1429.

2. Willis TG, Dyer MJ . The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 2000;96:808–822.

3. Tsujimoto Y, Cossman J, Jaffe E, et al. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;228:1440–1443.

4. Klapproth K, Wirth T . Advances in the understanding of MYC-induced lymphomagenesis. Br J Haematol 2010;149:484–497.

5. Smith SM, Anastasi J, Cohen KS, et al. The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma. Blood Cells Mol Dis 2010;45:317–323.

Cited by 215 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B cell receptor silencing reveals the origin of high-grade B cell lymphomas withMYCandBCL2rearrangements;2024-07-17

2. Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms;Modern Pathology;2024-04

3. Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies;Experimental Hematology & Oncology;2023-10-16

4. DOUBLE-HIT LYMPHOMA TRANSFORMATION DIAGNOSED VIA ENDOBRONCHIAL MASS IN THE PRESENCE OF COVID INFECTION COMPLICATIONS;CHEST;2023-10

5. Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy;Scientific Reports;2023-08-22